Strategies to mitigate inflammation in management of complex congenital heart disease complicated by “multisystem inflammatory syndrome in children”
暂无分享,去创建一个
Anil Kumar | R. Joshi | Neeraj Aggarwal | R. Joshi | M. Ray
[1] Денис Владимирович Борисенко,et al. Современные методы ограничения системного воспалительного ответа при коррекции врожденных пороков сердца у детей в условиях искусственного кровообращения , 2021 .
[2] C. Cecchetti,et al. Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report , 2021, Frontiers in Pediatrics.
[3] M. Malim,et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.
[4] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[5] C. Zöllner,et al. Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor α serum levels in cardiac surgery: a randomized controlled trial. , 2019, Minerva anestesiologica.
[6] N. Poirier,et al. Shone Complex: An Under-recognized Congenital Heart Disease With Substantial Morbidity in Adulthood. , 2017, The Canadian journal of cardiology.
[7] J. Kirklin,et al. Prophylactic peritoneal dialysis following cardiopulmonary bypass in children is associated with decreased inflammation and improved clinical outcomes. , 2014, Congenital heart disease.
[8] H. Wiles,et al. Surgical strategies and outcomes in patients with Shone complex: a retrospective review. , 2007, The Annals of thoracic surgery.
[9] M. Cavaglià,et al. Do peritoneal catheters remove pro-inflammatory cytokines after cardiopulmonary bypass in neonates? , 2000, The Annals of thoracic surgery.
[10] K M Taylor,et al. The systemic inflammatory response syndrome and cardiopulmonary bypass. , 2005, International journal of surgery.